Danone's Strong Results
Danone Announces Strong Q2 and H1 Results, Driven by Health Portfolio and Sales Growth
Anonymous
Danone posted strong results for the first half of 2026, with like-for-like sales rising +4.2% in Q2 and +3.5% for H1, according to MarketScreener. Total H1 sales reached €13,936 million, driven by both price and volume gains across its health-focused brands.
The French food giant's recurring operating income hit €1,854 million in H1 2026, as Yahoo Finance reported. Danone said the results show the strength of its "multi-engine growth model" across categories and geographies.
Price and Volume Both Push Sales Higher in H1
Danone's H1 growth came from two directions. Price added +11.8% to sales, while volume and product mix added +1.7%, according to MarketScreener. That combination shows Danone raised prices without losing too many shoppers.
Hyperinflation in certain markets also played a role. The company applied IAS29 accounting rules — a standard used when a country's currency loses value fast — which gave reported sales an extra lift, Yahoo Finance UK noted.
High-Protein and Medical Nutrition Lead the Charge
Demand for high-protein products stayed strong in Europe. Skyr, Kefir, and plant-based options all performed well, according to MarketScreener. These products sit at the core of Danone's push into health-focused eating.
Medical Nutrition also held up well. This category covers specialized food products for patients with specific health needs. Yahoo Finance reported that it remained one of Danone's reliable growth engines in the first half of the year.
North America and EMEA Show Signs of Recovery
Two areas that had struggled are now showing progress. Danone's everyday dairy and plant-based business in North America improved during H1. So did Infant Milk Formula sales in Europe, Middle East, and Africa, CA MarketScreener reported.
These were key areas to watch. North America EDP had faced pressure from competition and changing consumer habits. Improvement in both segments suggests Danone's turnaround efforts are starting to stick, according to Yahoo Finance UK.
Danone Bets Big on Health-Oriented Portfolio Strategy
Danone says it kept building out its health-focused product range during H1. The company continued adding products in "attractive health-oriented categories," Yahoo Finance reported. That is the heart of its long-term plan.
The results suggest the strategy is working. Broad-based growth across both categories and regions gives Danone room to invest further. The company's multi-engine model means it is not relying on just one product or market to drive results, CA MarketScreener noted.
Sentiment
NeutralNEGATIVENEUTRALPOSITIVE
Publishers
4
Articles
4
Reach
4
A
AnonymousAuthor
